Design-Stage Trial of Gentamicin in the Uniject Device

form. Supervisors collected and collated this information from the FCHV records on a monthlybasis.Figure 17. An FCHV practicing injection ofgentamicin in Uniject in an eggplant.Treatment register. A colored, pictorialregister, with individual pages for individualbabies (Appendix C), was used to record thehistory of treatment for a newborn in the eventof illness. The consent was written on the frontpage of the register. The register includedinformation about the classification of illness,consent given by the caretaker for treatment,and the treatment given to the sick newborn.Separate registers were used for FCHVs,VHWs, and facility-based health workers.Call form. The call form used in the MINIprogram to bring the VHW, MCHW, or AHW to the home to give the gentamicin injection wasused to “call” the supervisor to come and observe the FCHV giving gentamicin in Uniject (AppendixD).Data collection forms. Standard forms used in the MINI program were revised to collectinformation specific to this project. The information from the service registers was collected inthese data collection forms by project staff.3.7 Data collection and instrumentsThe NFHP hired a full-time consultant to serve as the field coordinator throughout the period of thestudy, and the existing MINI team provided additional support. Data were recorded by the healthworkers in their registers during the intervention. After completion of the intervention, focus groupdiscussions (FGDs) with FCHVs and in-depth interviews with supervisors (MCHWs/VHWs andhealth facility staff) were conducted to assess perceptions, feasibility, and acceptability of use ofgentamicin in Uniject, including interest in using the device long term. Both quantitative and qualitativedata were collected as noted in Table 4 below.Final Report(22) Gentamicin in Uniject: A Feasibility Study